5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 23.97▼ | 23.98▼ | 24.10▼ | 24.45▼ | 23.83▲ |
MA10 | 23.98▼ | 24.09▼ | 24.03▼ | 24.46▼ | 20.60▲ |
MA20 | 23.98▼ | 23.97▼ | 24.38▼ | 23.57▲ | 17.93▲ |
MA50 | 24.12▼ | 24.50▼ | 24.63▼ | 19.62▲ | 18.44▲ |
MA100 | 24.04▼ | 24.61▼ | 24.24▼ | 17.86▲ | 13.61▲ |
MA200 | 24.39▼ | 24.33▼ | 21.77▲ | 18.46▲ | 17.43▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.008▲ | -0.040▼ | -0.189▼ | 0.985▲ |
RSI | 39.855▼ | 41.334▼ | 42.398▼ | 57.406▲ | 64.908▲ |
STOCH | 53.142 | 43.175 | 65.793 | 52.278 | 70.890 |
WILL %R | -75.000▼ | -62.590 | -46.716 | -68.326 | -33.439 |
CCI | -80.843 | -77.442 | -37.995 | -27.912 | 98.675 |
Thursday, September 25, 2025 11:42 PM
CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephropathy (IgAN), Kidney Disease: ...
|
Thursday, September 11, 2025 10:00 AM
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on September 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants ...
|
Thursday, September 11, 2025 07:40 AM
Travere Therapeutics TVTX announced that the FDA, following further review of the supplemental new drug application (sNDA) for Filspari (sparsentan) in focal segmental glomerulosclerosis ("FSGS"), has ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 24.08 | 24.3879 | 23.61 | 23.90 | 1,856,053 |
29/09/25 | 25.38 | 25.46 | 22.055 | 24.04 | 3,220,306 |
26/09/25 | 24.86 | 25.48 | 24.39 | 25.30 | 1,261,095 |
25/09/25 | 24.42 | 25.25 | 24.1263 | 24.605 | 1,610,318 |
24/09/25 | 24.25 | 24.44 | 23.97 | 24.41 | 1,451,446 |
23/09/25 | 25.10 | 25.41 | 24.06 | 24.23 | 1,592,375 |
22/09/25 | 24.82 | 26.11 | 24.335 | 25.43 | 1,626,209 |
19/09/25 | 24.34 | 24.92 | 23.835 | 24.85 | 4,422,327 |
18/09/25 | 23.90 | 24.33 | 23.59 | 24.19 | 2,471,683 |
17/09/25 | 22.86 | 23.77 | 22.65 | 23.65 | 2,012,795 |
|
|
||||
|
|
||||
|
|